Table 2. Risk Factor Analysis of Pediatric PTC Patients Who Underwent Total Thyroidectomy, Comparing Unifocality and Multifocality.
Characteristics | Unifocality (n=42) | Multifocality (n=18) | p value | Univariate | Multivariate | |||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |||||
Age (yr) | 15.8±1.9 | 14.7±3.4 | 0.245 | 0.84 (0.67–1.06) | 0.149 | |||
Female sex | 34 (82.9) | 13 (76.5) | 0.715 | 0.67 (0.17–2.67) | 0.570 | |||
Primary tumor size (cm) | 2.5±1.3 | 3.7±2.1 | 0.010 | 1.61 (1.08–2.40) | 0.018 | 1.46 (0.74–2.88) | 0.281 | |
Primary tumor size >2 cm | 22 (53.7) | 11 (64.7) | 0.564 | 1.58 (0.49–5.10) | 0.441 | |||
Preoperative ultrasonography finding | ||||||||
Solid parenchyma | 35 (97.2) | 12 (100) | 0.999 | N/A | ||||
Calcifications | 26 (72.2) | 8 (66.7) | 0.726 | 0.77 (0.19–3.13) | 0.714 | |||
Irregular margins | 16 (44.4) | 7 (58.3) | 0.511 | 1.75 (0.47–6.57) | 0.407 | |||
Taller than wide | 2 (5.6) | 1 (8.3) | 0.999 | 1.55 (0.13–18.73) | 0.732 | |||
Hypoechoic | 28 (77.8) | 8 (66.7) | 0.462 | 0.57 (0.14–2.40) | 0.445 | |||
Ipsilateral nodule present | 8 (22.2) | 4 (33.3) | 0.462 | 1.75 (0.42–7.35) | 0.445 | |||
Contralateral nodule present | 13 (36.1) | 5 (41.7) | 0.743 | 1.26 (0.33–4.80) | 0.731 | |||
Final pathology* | ||||||||
PTC, classical | 26 (63.4) | 8 (47.1) | 0.380 | 0.51 (0.16–1.61) | 0.253 | |||
PTC, diffuse sclerosing | 6 (14.6) | 3 (17.6) | 0.999 | 1.25 (0.27–5.70) | 0.773 | |||
PTC, tall cell | 4 (9.8) | 3 (17.6) | 0.407 | 1.98 (0.39–9.99) | 0.407 | |||
PTC, clear cell | 2 (4.9) | 2 (11.8) | 0.573 | 2.60 (0.34–20.17) | 0.361 | |||
PTC, follicular variant | 1 (2.4) | 1 (5.9) | 0.504 | 2.50 (0.15–42.44) | 0.526 | |||
Bilaterality | 9 (22.0) | 8 (47.1) | 0.067 | 3.16 (0.95–10.55) | 0.061 | |||
Gross ETE | 5 (12.2) | 7 (41.2) | 0.028 | 5.04 (1.31–19.34) | 0.018 | 11.70 (0.56–44.95) | 0.113 | |
Number of central LN metastasis | 6.4±5.7 | 10.2±5.7 | 0.025 | 1.09 (0.99–1.21) | 0.076 | |||
Number of lateral LN metastasis | 13.2±8.7 | 17.3±8.8 | 0.265 | 1.16 (1.01–1.32) | 0.030 | 1.14 (0.95–1.36) | 0.163 |
OR, odds ratio; CI, confidence interval; PTC, papillary thyroid cancer; ETE, extrathyroidal extension; LN, lymph node.
Data are presented as mean±standard deviation or n (%).
*PTC, others were not included since no patient had multifocal disease.